Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Matsoukas

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Frontiers in Pharmacology|September 1, 2022
Smart therapies against global pandemics: A potential of short peptidesVasso Apostolopoulos, Joanna Bojarska, Jack Feehan, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 2, 2005
Structure elucidation and conformational study of V8: a novel synthetic non peptide AT(1) antagonistPanagiotis Zoumpoulakis, Aggeliki Politi, Simona Golic Grdadolnik, et al.
Amino Acids|May 27, 2009
NMR structural elucidation of myelin basic protein epitope 83-99 implicated in multiple sclerosisZinovia Spyranti, Theodore Tselios, George Deraos, et al.
Amino Acids|June 2, 2009
Design, synthesis and biological evaluation of non-peptide PAR1 thrombin receptor antagonists based on small bifunctional templates: arginine and phenylalanine side chain groups are keys for receptor activityMaria-Eleni Androutsou, Mahmoud Saifeddine, Morley D Hollenberg, et al.
Protein and Peptide Letters|January 29, 2008
Solid phase synthesis of a glycopeptide analogue using the acid sensitive 4-methoxybenzhydryl bromide resinTheodore Tselios, Konstantinos Kelaidonis, Amalia Resvani, et al.
Immunotherapy|September 5, 2014
Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugationMaria Katsara, Spyros Deraos, Theodore V Tselios, et al.
Molecules (Basel, Switzerland)|January 28, 2021
From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 TherapyJohn Matsoukas, Vasso Apostolopoulos, Anthony Zulli, et al.
Molecules (Basel, Switzerland)|November 7, 2014
Rational design and synthesis of altered peptide ligands based on human myelin oligodendrocyte glycoprotein 35-55 epitope: inhibition of chronic experimental autoimmune encephalomyelitis in miceTheodore Tselios, Mihalis Aggelidakis, Anthi Tapeinou, et al.
Journal of Medicinal Chemistry|December 17, 2008
Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosisMaria Katsara, George Deraos, Theodore Tselios, et al.
Journal of Mass Spectrometry : JMS|April 29, 2008
In vivo evaluation and in vitro metabolism of leuprolide in mice--mass spectrometry-based biomarker measurement for efficacy and toxicityZacharias D Sofianos, Theodora Katsila, Nikolaos Kostomitsopoulos, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Frontiers in Pharmacology|September 1, 2022
Smart therapies against global pandemics: A potential of short peptidesVasso Apostolopoulos, Joanna Bojarska, Jack Feehan, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 2, 2005
Structure elucidation and conformational study of V8: a novel synthetic non peptide AT(1) antagonistPanagiotis Zoumpoulakis, Aggeliki Politi, Simona Golic Grdadolnik, et al.
Amino Acids|May 27, 2009
NMR structural elucidation of myelin basic protein epitope 83-99 implicated in multiple sclerosisZinovia Spyranti, Theodore Tselios, George Deraos, et al.
Amino Acids|June 2, 2009
Design, synthesis and biological evaluation of non-peptide PAR1 thrombin receptor antagonists based on small bifunctional templates: arginine and phenylalanine side chain groups are keys for receptor activityMaria-Eleni Androutsou, Mahmoud Saifeddine, Morley D Hollenberg, et al.
Protein and Peptide Letters|January 29, 2008
Solid phase synthesis of a glycopeptide analogue using the acid sensitive 4-methoxybenzhydryl bromide resinTheodore Tselios, Konstantinos Kelaidonis, Amalia Resvani, et al.
Immunotherapy|September 5, 2014
Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugationMaria Katsara, Spyros Deraos, Theodore V Tselios, et al.
Molecules (Basel, Switzerland)|January 28, 2021
From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 TherapyJohn Matsoukas, Vasso Apostolopoulos, Anthony Zulli, et al.
Molecules (Basel, Switzerland)|November 7, 2014
Rational design and synthesis of altered peptide ligands based on human myelin oligodendrocyte glycoprotein 35-55 epitope: inhibition of chronic experimental autoimmune encephalomyelitis in miceTheodore Tselios, Mihalis Aggelidakis, Anthi Tapeinou, et al.
Journal of Medicinal Chemistry|December 17, 2008
Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosisMaria Katsara, George Deraos, Theodore Tselios, et al.
Journal of Mass Spectrometry : JMS|April 29, 2008
In vivo evaluation and in vitro metabolism of leuprolide in mice--mass spectrometry-based biomarker measurement for efficacy and toxicityZacharias D Sofianos, Theodora Katsila, Nikolaos Kostomitsopoulos, et al.
Pageof 7